Drugs & Devices
FDA Inspectors Find Quality Control Issues at Semaglutide Facility
Burkholderia cepacian bacteria and other issues were found at a Novo Nordisk facility where semaglutide is made for its Type 2 diabetes drug Rybelsus.
Calling this number connects you with a Consumer Notice, LLC representative. We will direct you to one of our trusted legal partners for a free case review.
Consumer Notice, LLC's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
844-420-1914